Published in Korean Circ J on July 25, 2014
Interesting Correlation Between the Circulating Pentraxin 3 and Cardiac Rehabilitation Program Outcomes in Coronary Artery Bypass Grafting Patients. Cardiol Res (2016) 0.75
Evaluation of pentraxin-3 level and its related factors in patients undergoing primary percutaneous coronary intervention. ARYA Atheroscler (2017) 0.75
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17
Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol (2003) 16.23
The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention (2005) 5.16
Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med (2008) 4.96
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J (2011) 3.29
Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials (2009) 2.92
Assessment of the SYNTAX score in the Syntax study. EuroIntervention (2009) 2.24
Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization. JACC Cardiovasc Interv (2011) 1.61
Prognostic value of the Syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease. Catheter Cardiovasc Interv (2009) 1.56
Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol (2007) 1.32
Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization. JACC Cardiovasc Interv (2010) 1.31
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol (2010) 1.21
A new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score. Circ Cardiovasc Interv (2010) 1.19
SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements. Circ Cardiovasc Interv (2011) 1.04
A simple method for estimating relative risk using logistic regression. BMC Med Res Methodol (2012) 1.03
Widening clinical applications of the SYNTAX Score. Heart (2013) 0.92
Comparison of the predictive value of EuroSCORE, SYNTAX score, and clinical SYNTAX score for outcomes of patients undergoing percutaneous coronary intervention for unprotected left main coronary artery disease. Catheter Cardiovasc Interv (2012) 0.92
Usefulness of the SYNTAX score to predict "no reflow" in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am J Cardiol (2011) 0.90
Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris. J Investig Med (2013) 0.88
Contemporary and evolving risk scoring algorithms for percutaneous coronary intervention. Heart (2011) 0.84
Initial SYNTAX score predicts major adverse cardiac events after primary percutaneous coronary intervention. Angiology (2013) 0.83
Incremental diagnostic value of circulating pentraxin in patients with intermediate risk of coronary artery disease. Heart (2013) 0.82
Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: use, pitfalls, and new directions. Am Heart J (2011) 0.78
Opium addiction increases interleukin 1 receptor antagonist (IL-1Ra) in the coronary artery disease patients. PLoS One (2012) 0.91
Incremental diagnostic value of circulating pentraxin in patients with intermediate risk of coronary artery disease. Heart (2013) 0.82
Prehypertension Tsunami: A Decade Follow-Up of an Iranian Adult Population. PLoS One (2015) 0.80
A simple clinical model predicted diabetes progression among prediabetic individuals. Diabetes Res Clin Pract (2012) 0.80
Added value of total serum nitrate/nitrite for prediction of cardiovascular disease in middle east caucasian residents in Tehran. Nitric Oxide (2016) 0.77
Risk Factors for Incidence of Cardiovascular Diseases and All-Cause Mortality in a Middle Eastern Population over a Decade Follow-up: Tehran Lipid and Glucose Study. PLoS One (2016) 0.76
The Safety of Using Large Amount (30 cc) of Onyx (Ethylene-vinyl Alcohol Copolymer) for the Treatment of Large Type II Endoleak after Endovascular Repair of Abdominal Aortic Aneurysm. Int J Angiol (2016) 0.75
Accidental left circumflex artery to right lung fistula in a suspected case of pulmonary hypertension. Case Rep Cardiol (2014) 0.75
Analysis of rs6725887 in the WD Repeat Protein 12 in Association with Coronary Artery Disease in Iranian Patients. Int J Mol Cell Med (2015) 0.75
Adherence to Antihypertensive Medications in Iranian Patients. Int J Hypertens (2016) 0.75
Visual-Functional Mismatch Between Coronary Angiography, Fractional Flow Reserve, and Quantitative Coronary Angiography. Int J Angiol (2015) 0.75
Comparison between Intracoronary Abciximab and Intravenous Eptifibatide Administration during Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction. J Tehran Heart Cent (2013) 0.75
Sex-specific predictors of the prehypertension-to-hypertension progression: community-based cohort of a West-Asian population. Eur J Prev Cardiol (2013) 0.75